| Dr William Shevin, MD | |
|
50 Applewood Dr, Woodstock, CT 06281 | |
| (860) 928-4040 | |
| (860) 928-0733 |
| Full Name | Dr William Shevin |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 50 Applewood Dr, Woodstock, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629168059 | NPI | - | NPPES |
| CT5191 | Other | HEALTHNET | |
| 010057604 | Other | RAILROAD MEDICARE | |
| 782878 | Other | CONNECTICARE | |
| 010021770CT01 | Other | CT | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | CT021770 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Shevin, MD 50 Applewood Dr, Woodstock, CT 06281 Ph: (860) 928-4040 | Dr William Shevin, MD 50 Applewood Dr, Woodstock, CT 06281 Ph: (860) 928-4040 |
News Archive
NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009.
"A new report released by the Chicago Council on Global Affairs, 'Bringing Agriculture to the Table: How Agriculture and Food Can Play a Role in Preventing Chronic Disease,' calls on the agriculture and food sector to play a role in mitigating the global rise in non-communicable diseases (NCDs) and identifies new opportunities for those in health and agriculture to work together to promote better health."
A special cream enriched with bacteria-busting viruses has been developed by scientists in Britain and it could eradicate deadly superbugs such as MRSA from hospitals.
The Michael J. Fox Foundation for Parkinson's Research announced awards totaling approximately $10.1 million for five new clinical studies and 14 pre-clinical therapeutic development projects. The funding includes $2.5 million to drive four new clinical trials under the Clinical Intervention Awards, one of the Foundation's Edmond J. Safra Core Programs for PD Research.
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.
› Verified 9 days ago
Aimee Eggleston, General Practice Medicare: Not Enrolled in Medicare Practice Location: 483 Center Rd, Woodstock, CT 06281 Phone: 860-942-3365 |